重复性眼性前庭诱发肌源性电位在重症肌无力中的应用
本研究验证重复性眼性前庭诱发肌源性电位(RoVEMP)对重症肌无力(MG)的诊断价值,纳入92例MG患者、22例健康对照、33例其他神经肌肉病对照及6例其他肌无力综合征患者。结果示MG患者平均递减幅度显著高于对照组,以神经肌肉病对照为参照,切点≥14.3%时敏感度67%、特异度82%,在眼肌型MG及血清阴性MG中亦有辅助诊断价值。
要点
- RoVEMP可测量眼外肌神经肌肉传递,补充RNS和单纤维肌电图的不足。
- 切点≥14.3%时敏感度67%、特异度82%,眼肌型MG敏感度80%。
- 血清阴性且RNS阴性的眼肌无力患者中,RoVEMP有辅助诊断价值。
核心结论
- RoVEMP是一种新型神经生理学检查,能测量眼外肌的神经肌肉传递,在诊断困难的患者中具有明确辅助价值。
研究设计与样本
- 研究纳入92例MG患者、22例健康对照、33例其他神经肌肉病对照、4例Lambert-Eaton肌无力综合征和2例先天性肌无力综合征患者,行RoVEMP检测。
主要发现
- MG患者平均递减幅度为28.4%±32.2,显著高于健康对照的3.2%±13.9(p<0.001)和神经肌肉病对照的3.8%±26.9(p<0.001)。
- 以神经肌肉病对照为参照,切点≥14.3%时敏感度67%、特异度82%。
- 眼肌型MG敏感度80%,全身型MG敏感度63%。
- 7例血清阴性MG伴孤立眼肌无力患者中6例RoVEMP阳性;10例血清阴性且RNS阴性的MG患者中73%RoVEMP异常。
- 递减幅度与距上次吡啶斯的明摄入时间相关(B=5.40;p=0.019)。
关键数值与推荐
- RoVEMP切点≥14.3%时,以神经肌肉病对照为参照,敏感度67%、特异度82%。
- 眼肌型MG敏感度80%,全身型MG敏感度63%。
临床怎么用
- 对于抗体阴性、RNS阴性且孤立眼肌无力的诊断困难患者,RoVEMP可辅助支持MG诊断。
局限性
- 本研究提供Class III证据,尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To validate the repetitive ocular vestibular evoked myogenic potentials (RoVEMP) test for diagnostic use in myasthenia gravis (MG) and to investigate its value in diagnostically challenging subgroups. METHODS: The RoVEMP test was performed in 92 patients with MG, 22 healthy controls, 33 patients with a neuromuscular disease other than MG (neuromuscular controls), 4 patients with Lambert-Eaton myasthenic syndrome, and 2 patients with congenital myasthenic syndrome. RESULTS: Mean decrement was significantly higher in patients with MG (28.4% ± 32.2) than in healthy controls (3.2% ± 13.9; p < 0.001) or neuromuscular controls (3.8% ± 26.9; p < 0.001). With neuromuscular controls as reference, a cutoff of ≥14.3% resulted in a sensitivity of 67% and a specificity of 82%. The sensitivity of the RoVEMP test was 80% in ocular MG and 63% in generalized MG. The RoVEMP test was positive in 6 of 7 patients with seronegative MG (SNMG) with isolated ocular weakness. Of 10 patients with SNMG with negative repetitive nerve stimulation (RNS) results, 73% had an abnormal RoVEMP test. The magnitude of decrement was correlated with the time since the last intake of pyridostigmine (B = 5.40; p = 0.019). CONCLUSIONS: The RoVEMP test is a new neurophysiologic test that, in contrast to RNS and single-fiber EMG, is able to measure neuromuscular transmission of extraocular muscles, which are the most affected muscles in MG. Especially in diagnostically challenging patients with negative antibody tests, negative RNS results, and isolated ocular muscle weakness, the RoVEMP test has a clear added value in supporting the diagnosis of MG. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that RoVEMP distinguishes MG from other neuromuscular diseases.
引用
- de Meel RHP, Keene KR, Wirth MA, et al. Repetitive ocular vestibular evoked myogenic potentials in myasthenia gravis. Neurology. 2020. PMID: 32217778. doi:10.1212/WNL.0000000000009306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。